Literature DB >> 29920724

Afterdepolarizations and triggered activity as a mechanism for clinical arrhythmias.

Andrew L Wit1.   

Abstract

Afterdepolarizations cause triggered arrhythmias. One kind occurs after repolarization is complete, delayed afterdepolarizations (DADs). Another occurs as an interruption in repolarization, early afterdepolarizations (EADs). Afterdepolarizations initiate arrhythmias when they depolarize membrane potential to threshold potential for triggering action potentials. DADs usually occur mostly when Ca2+ in the sarcoplasmic reticulum (SR) is elevated. The SR leaks some of the Ca2+ into the myoplasm through Ca2+ release channels controlled by ryanodine receptors (RyR2) during diastole. The Na+ -Ca2+ exchanger extrudes elevated diastolic Ca2+ from the cell in exchange for Na+ (1 Ca2+ for 3 Na+ ) generating inward current causing DADs. DAD amplitude increases with decreasing cycle length, causing triggered activity during an increase in heart rate or during programmed electrical stimulation (PES). Coupling interval of the first triggered impulse is directly related to initiating cycle length. EADs are associated with an increased action potential duration (APD) causing long QT (LQT). EADs are caused by net inward currents (ICaL , INCX ) as a consequence. Hundreds of mutations can cause congenital LQT by altering repolarizing ion channels. Acquired LQT results from drug interaction with repolarizing ion channels. EAD-triggered ventricular tachycardia is polymorphic and called "torsade de pointes." Effects of PES on EAD-triggered activity is related to effects of cycle length on APD. Shortening cycle length prevents EADs by accelerating repolarization. Typical PES protocols inhibit formation of EADs which can be therapeutic.
© 2018 Wiley Periodicals, Inc.

Entities:  

Keywords:  afterdepolarizations; electrical stimulation; triggered arrhythmias

Year:  2018        PMID: 29920724     DOI: 10.1111/pace.13419

Source DB:  PubMed          Journal:  Pacing Clin Electrophysiol        ISSN: 0147-8389            Impact factor:   1.976


  11 in total

1.  CLOCK-BMAL1 regulates circadian oscillation of ventricular arrhythmias in failing hearts through β1 adrenergic receptor.

Authors:  Zihao Zhou; Jiamin Yuan; Didi Zhu; Yanhong Chen; Zhiyong Qian; Yao Wang; Peibin Ge; Quanpeng Wang; Xiaofeng Hou; Jiangang Zou
Journal:  Am J Transl Res       Date:  2020-10-15       Impact factor: 4.060

2.  Activation of TRPC (Transient Receptor Potential Canonical) Channel Currents in Iron Overloaded Cardiac Myocytes.

Authors:  Natthaphat Siri-Angkul; Zhen Song; Nadezhda Fefelova; Judith K Gwathmey; Siriporn C Chattipakorn; Zhilin Qu; Nipon Chattipakorn; Lai-Hua Xie
Journal:  Circ Arrhythm Electrophysiol       Date:  2021-01-08

Review 3.  Recent Advances in Pharmacological and Non-Pharmacological Strategies of Cardioprotection.

Authors:  Afonso Caricati-Neto; Paolo Ruggero Errante; Francisco Sandro Menezes-Rodrigues
Journal:  Int J Mol Sci       Date:  2019-08-16       Impact factor: 5.923

4.  Electrophysiological Abnormalities in VLCAD Deficient hiPSC-Cardiomyocytes Can Be Improved by Lowering Accumulation of Fatty Acid Oxidation Intermediates.

Authors:  Suzan J G Knottnerus; Isabella Mengarelli; Rob C I Wüst; Antonius Baartscheer; Jeannette C Bleeker; Ruben Coronel; Sacha Ferdinandusse; Kaomei Guan; Lodewijk IJlst; Wener Li; Xiaojing Luo; Vincent M Portero; Ying Ulbricht; Gepke Visser; Ronald J A Wanders; Frits A Wijburg; Arie O Verkerk; Riekelt H Houtkooper; Connie R Bezzina
Journal:  Int J Mol Sci       Date:  2020-04-08       Impact factor: 5.923

5.  Inflammation as a Risk Factor in Cardiotoxicity: An Important Consideration for Screening During Drug Development.

Authors:  Chiara Campana; Rafael Dariolli; Mohamed Boutjdir; Eric A Sobie
Journal:  Front Pharmacol       Date:  2021-04-19       Impact factor: 5.810

6.  Infant with 2:1 atrioventricular block after surgery for congenital heart disease: What's the mechanism?

Authors:  Christopher L Johnsrude
Journal:  HeartRhythm Case Rep       Date:  2021-10-30

7.  QTc interval prolongation in the patients with primary biliary cholangitis.

Authors:  Zihao Wang; Rongkai Qian; Yanhua Wang; Lingfei Mo; Bomiao Ju; Nan Hu; Pei Wang; Lan He; Jing Wang
Journal:  Ann Noninvasive Electrocardiol       Date:  2021-12-02       Impact factor: 1.468

8.  Suppression of ventricular arrhythmias by targeting late L-type Ca2+ current.

Authors:  Marina Angelini; Arash Pezhouman; Nicoletta Savalli; Marvin G Chang; Federica Steccanella; Kyle Scranton; Guillaume Calmettes; Michela Ottolia; Antonios Pantazis; Hrayr S Karagueuzian; James N Weiss; Riccardo Olcese
Journal:  J Gen Physiol       Date:  2021-10-26       Impact factor: 4.000

Review 9.  Ventricular Arrhythmias in Ischemic Cardiomyopathy-New Avenues for Mechanism-Guided Treatment.

Authors:  Matthew Amoni; Eef Dries; Sebastian Ingelaere; Dylan Vermoortele; H Llewelyn Roderick; Piet Claus; Rik Willems; Karin R Sipido
Journal:  Cells       Date:  2021-10-01       Impact factor: 6.600

Review 10.  The Emergence of Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes (hiPSC-CMs) as a Platform to Model Arrhythmogenic Diseases.

Authors:  Marc Pourrier; David Fedida
Journal:  Int J Mol Sci       Date:  2020-01-19       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.